183 related articles for article (PubMed ID: 36308358)
1. The Immune-related ceRNA Network in Prognosis of Cervical Cancer.
Dhandapani H; Bose M; Kesavan S
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3347-3354. PubMed ID: 36308358
[TBL] [Abstract][Full Text] [Related]
2. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
4. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
Chen P; Zhang W; Chen Y; Zheng X; Yang D
Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
[TBL] [Abstract][Full Text] [Related]
6. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Wang T; Zhang XD; Hua KQ
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
[TBL] [Abstract][Full Text] [Related]
7. Construction of a New Immune-Related Competing Endogenous RNA Network with Prognostic Value in Lung Adenocarcinoma.
Liu L; Li J; Fan C; Wen M; Li C; Sun W; Wang W
Mol Biotechnol; 2024 Feb; 66(2):300-310. PubMed ID: 37118319
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma.
Yang Y; Feng L; Wang R; Ma H; He S; Fang J
Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
Chen J; Song Y; Li M; Zhang Y; Lin T; Sun J; Wang D; Liu Y; Guo J; Yu W
BMC Cancer; 2021 Mar; 21(1):255. PubMed ID: 33750326
[TBL] [Abstract][Full Text] [Related]
12. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
13. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
[TBL] [Abstract][Full Text] [Related]
14. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
[TBL] [Abstract][Full Text] [Related]
17. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
Yang L; Ma TJ; Zhang YB; Wang H; An RH
Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
20. Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.
Li L; Guo Q; Lan G; Liu F; Wang W; Lv X
Sci Rep; 2022 Jun; 12(1):10691. PubMed ID: 35739227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]